4//SEC Filing
CATABASIS PHARMACEUTICALS INC 4
Accession 0001104659-15-049013
$ATXSCIK 0001454789operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:45 PM ET
Size
10.7 KB
Accession
0001104659-15-049013
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Conversion
Series B Preferred Stock
2015-06-30−105,229→ 0 total→ Common Stock (8,189 underlying) - Conversion
Common Stock
2015-06-30+66,657→ 245,683 total - Conversion
Common Stock
2015-06-30+8,189→ 253,872 total - Conversion
Series A Preferred Stock
2015-06-30−856,548→ 0 total→ Common Stock (66,657 underlying)
Footnotes (1)
- [F1]The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454789
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:45 PM ET
- Size
- 10.7 KB